SB 691 Pennsylvania Senate · 2025-2026 Regular Session

An Act amending Titles 35 (Health and Safety), 42 (Judiciary and Judicial Procedure) and 61 (Prisons and Parole) of the Pennsylvania Consolidated Statutes, establishing the Nonnarcotic Medication Substance Use Disorder Treatment Program; in organization and jurisdiction of courts of common pleas, providing for court assessments for substance use disorder treatment; in other criminal provisions, further providing for supervisory relationship to offenders; and, in Pennsylvania Board of Probation and Parole, further providing for supervisory relationship to offenders.

SB 691 establishes the Nonnarcotic Medication Substance Use Disorder Treatment Program within Pennsylvania's Department of Drug and Alcohol Programs. This program provides grants to local agencies, known as single county authorities, to offer comprehensive nonnarcotic medication-assisted treatment to offenders with substance use disorders. Eligible providers will assess offenders receiving various court-imposed sentences for drug-related offenses and offer individualized treatment plans, including FDA-approved nonnarcotic medication and counseling. The bill also allows courts to order substance use disorder assessments for these offenders and updates provisions related to their supervision by probation and parole.
Bill status in committee 1 of 4 stages cleared
Introduction
Apr 2025
Committee Review
Floor Vote
Governor
Introduced Apr 28, 2025 Last action Apr 28, 2025